The E3N-EPIC cohort of 2004 indicates that the association between hormone replacement and breast cancer risk most likely varies according to the type of synthetic progesterone used. There was no or little increase in risk with estrogens used alone or combined with micronized (bioidentical) progesterone.
About the author (Aleksander Bodnar, M.D.)
For more than 25 years, Dr. Bodnar has dedicated his practice to helping patients achieve a healthy life balance and spreading knowledge about wellness and healing. He approaches his practice using scientifically proven therapies and advanced medical technologies for early detection, and treatment of age-related physiological and cognitive dysfunctions.